X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-mesothelin immunotoxin (14) 14
index medicus (14) 14
humans (13) 13
phase-i trial (8) 8
animals (7) 7
oncology (7) 7
article (6) 6
cancer (6) 6
antibodies, monoclonal - therapeutic use (5) 5
immunotoxins - therapeutic use (5) 5
ss1p (5) 5
antineoplastic agents - pharmacology (4) 4
cytotoxic activity (4) 4
immunotherapy (4) 4
immunotoxins - pharmacology (4) 4
infusion (4) 4
mice (4) 4
phase-i (4) 4
pseudomonas exotoxin (4) 4
recombinant immunotoxin (4) 4
antibodies, monoclonal - immunology (3) 3
care and treatment (3) 3
cell line, tumor (3) 3
exotoxins - pharmacology (3) 3
exotoxins - therapeutic use (3) 3
immunotoxins - immunology (3) 3
mesothelin (3) 3
recombinant fusion proteins - pharmacology (3) 3
rfb4-pe38 bl22 (3) 3
adp ribose transferases - chemistry (2) 2
adp ribose transferases - immunology (2) 2
adp ribose transferases - pharmacology (2) 2
adult (2) 2
antigens, neoplasm - immunology (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antitumor-activity (2) 2
b-cell epitopes (2) 2
b-lymphocytes - drug effects (2) 2
b-lymphocytes - immunology (2) 2
bacterial toxins - chemistry (2) 2
bacterial toxins - immunology (2) 2
bacterial toxins - pharmacology (2) 2
biochemistry & molecular biology (2) 2
cancer therapy (2) 2
chemotherapy (2) 2
clinical trials as topic (2) 2
denileukin diftitox (2) 2
diagnosis (2) 2
dosage and administration (2) 2
drug discovery (2) 2
drug synergism (2) 2
exotoxins - chemistry (2) 2
exotoxins - immunology (2) 2
expression (2) 2
female (2) 2
gpi-linked proteins - immunology (2) 2
health aspects (2) 2
immunogenicity (2) 2
immunology (2) 2
immunosuppression (2) 2
immunotoxin (2) 2
immunotoxins - adverse effects (2) 2
immunotoxins - chemistry (2) 2
leukemia (2) 2
leukemia - drug therapy (2) 2
male (2) 2
medicine, research & experimental (2) 2
monoclonal antibody (2) 2
moxetumomab pasudotox (2) 2
neoplasms - immunology (2) 2
pancreatic cancer (2) 2
pancreatic neoplasms - immunology (2) 2
pharmacology & pharmacy (2) 2
recombinant fusion proteins - chemistry (2) 2
recombinant fusion proteins - metabolism (2) 2
recombinant immunotoxins (2) 2
t-lymphocytes - immunology (2) 2
therapy (2) 2
toxin (2) 2
treatment outcome (2) 2
virulence factors - chemistry (2) 2
virulence factors - immunology (2) 2
virulence factors - pharmacology (2) 2
1st-line therapy (1) 1
adjuvant chemotherapy (1) 1
adoptive immunotherapy (1) 1
adp ribose transferases - genetics (1) 1
adp ribose transferases - metabolism (1) 1
adp ribose transferases - therapeutic use (1) 1
adult t-cell leukemia (1) 1
advanced solid tumors (1) 1
aged (1) 1
amino acid sequence (1) 1
anti-b4-blocked ricin (1) 1
anti-mesothelin therapy (1) 1
anti-tac (1) 1
antiangiogenic therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The FEBS Journal, ISSN 1742-464X, 12/2011, Volume 278, Issue 23, pp. 4683 - 4700
Journal Article
Journal Article
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 06/2015, Volume 26, Issue 6, pp. 1120 - 1128
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 01/2014, Volume 37, Issue 1, pp. 8 - 15
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 11/2015, Volume 75, Issue 17, pp. 1993 - 2016
Through years of evolutionary selection pressures, organisms have developed potent toxins that coincidentally have marked antineoplastic activity. These... 
IMMUNOTOXIN RFB4(DSFV)-PE38 BL22 | PEGYLATED LIPOSOMAL DOXORUBICIN | EPOTHILONE-B ANALOG | DRUG-RESISTANT PHENOTYPE | GEMTUZUMAB OZOGAMICIN | PHASE-I TRIAL | METASTATIC BREAST-CANCER | ERIBULIN MESYLATE E7389 | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ANTI-MESOTHELIN IMMUNOTOXIN | CHRONIC MYELOID-LEUKEMIA | Dioxoles - therapeutic use | Diphtheria Toxin - pharmacology | Recombinant Fusion Proteins - pharmacology | Furans - pharmacology | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Epothilones - pharmacology | Drug Discovery - methods | Antineoplastic Agents - therapeutic use | Biological Products - pharmacology | Epothilones - therapeutic use | Harringtonines - therapeutic use | Furans - therapeutic use | TOR Serine-Threonine Kinases - antagonists & inhibitors | Diphtheria Toxin - therapeutic use | Immunoconjugates - pharmacology | Cytochalasins - pharmacology | Dioxoles - pharmacology | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Ketones - therapeutic use | Cytochalasins - therapeutic use | Biological Products - therapeutic use | Ketones - pharmacology | Tetrahydroisoquinolines - pharmacology | Tetrahydroisoquinolines - therapeutic use | Withanolides - pharmacology | Harringtonines - pharmacology | Interleukin-2 - pharmacology | Withanolides - therapeutic use | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2009, Volume 106, Issue 9, pp. 3360 - 3365
Journal Article
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 208, pp. 208fs38 - 208fs38
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 12/2019, Volume 144, p. 102815
Malignant pleural mesothelioma (MPM) is a rare cancer of the pleural surfaces frequently related to asbestos exposure. It is characterized by a poor prognosis... 
Malignant pleural mesothelioma | Molecular | Anti-mesothelin therapy | Antiangiogenic therapy | Immunotherapy | Target therapy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.